AGA Joins Innovate UK GBIP Sweden AMR Programme
Through this international programme, AGA Nanotech will explore AMR collaboration opportunities in Sweden, presenting Battlestar™ as a breakthrough in tackling biofilms and drug-resistant pathogens.AGA Nanotech has been selected to participate in the Global Business Innovation Programme (GBIP) Sweden: AMR, funded by Innovate UK. This six-day innovation visit to Sweden will connect AGA Nanotech with major AMR stakeholders and opportunities to collaborate internationally. AGA Nanotech’s flagship technology, Battlestar™, will be showcased for its unique ability to provide broad-spectrum efficacy, potent antibiofilm activity, low cytotoxicity, and, with its multimodal action, does not give rise to resistance. Having completed the pre-visit workshops October, AGA are in the best positon to present Battlestar to prospective partners at the in-country visit scheduled for March 16–21, 2025.